Humana Inc. (HUM)
Stock analysis · NYSE · Healthcare · Medical - Healthcare Plans
Humana Inc. (HUM) is a publicly traded company in the Healthcare sector. Latest price: $419.85. Market cap $50.42B. Trailing PE 39.42. Dividend yield 0.84%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 6 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Earnings
Proprietary Signals
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy managemen…
Valuation
| P/E (TTM) | 39.42× |
|---|---|
| P/S (TTM) | 0.35× |
| P/B | 2.63× |
| P/FCF (TTM) | -113.80× |
| EV / EBITDA | 18.65× |
| EV / Sales | 0.40× |
| Earnings Yield | 2.53% |
| Free Cash Flow Yield | -0.88% |
| Dividend Yield | 0.84% |
Fundamentals
| Enterprise Value | $57.77B |
|---|---|
| Revenue (TTM) | $145.68B |
| Net Income (TTM) | $1.28B |
| Free Cash Flow (TTM) | $131.02M |
| Net Debt | $7.35B |
| Working Capital | $17.08B |
| Gross Margin | 13.65% |
| Operating Margin | 1.39% |
| Net Margin | 0.88% |
| Return on Equity | 6.91% |
| Return on Invested Capital | 4.52% |
Peers
Recent News
- Baron Health Care Fund: Q3 2026 New Positions And Exits
- Humana Gains From Premium Growth Despite Rising Benefit Costs
- Meta Is About to Show Whether Bigger AI Capex Still Wins
- Should Value Investors Buy Humana (HUM) Stock?
- 3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking
Related
Browse more tickers: sitemap